glp 1 bowel issues Adverse effects of GLP-1 class drugs. Gastrointestinal are GLP-1R Agonists for Weight Loss

Patient Readiness and Expectations The successful introduction of GLP-1 depends on patient understanding, psychological readiness, and long-term commitment: Mechanism Awareness: Patients must understand that GLP-1 facilitates a caloric deficit and is not a substitute for dietary and lifestyle management

While a direct comparison is hard (due to differences in study designs), it seems that tirzepatide is a better overall drug for weight loss (and also shows greater reduction in A1C)

Developed by AstraZeneca, it functions by enhancing insulin secretion and suppressing inappropriately high glucagon levels

Storage & Stability Before Reconstitution : Store lyophilized powder at -20C (-4F) in a cool, dry, and dark environment

ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer